CA2676415A1 - Genemap of the human genes associated with endometriosis - Google Patents

Genemap of the human genes associated with endometriosis Download PDF

Info

Publication number
CA2676415A1
CA2676415A1 CA002676415A CA2676415A CA2676415A1 CA 2676415 A1 CA2676415 A1 CA 2676415A1 CA 002676415 A CA002676415 A CA 002676415A CA 2676415 A CA2676415 A CA 2676415A CA 2676415 A1 CA2676415 A1 CA 2676415A1
Authority
CA
Canada
Prior art keywords
gene
tables
expression
nucleic acid
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002676415A
Other languages
English (en)
French (fr)
Inventor
Abdelmajid Belouchi
John Verner Raelson
Bruno Paquin
Sandy Briand
Daniel Dubois
Paul Van Eerdewegh
Jonathan Segal
Randall David Little
Tim Keith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genizon Biosciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2676415A1 publication Critical patent/CA2676415A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002676415A 2007-02-06 2008-02-06 Genemap of the human genes associated with endometriosis Abandoned CA2676415A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US89961507P 2007-02-06 2007-02-06
US60/899,615 2007-02-06
US94856507P 2007-07-09 2007-07-09
US60/948,565 2007-07-09
PCT/US2008/001529 WO2008123901A2 (en) 2007-02-06 2008-02-06 Genemap of the human genes associated with endometriosis

Publications (1)

Publication Number Publication Date
CA2676415A1 true CA2676415A1 (en) 2008-10-16

Family

ID=39831514

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002676415A Abandoned CA2676415A1 (en) 2007-02-06 2008-02-06 Genemap of the human genes associated with endometriosis

Country Status (3)

Country Link
EP (1) EP2118321A4 (de)
CA (1) CA2676415A1 (de)
WO (1) WO2008123901A2 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
US9316588B2 (en) 2010-12-24 2016-04-19 Otsuka Pharmaceutical Co., Ltd. Bioassay method for detecting physiologically active substance
CA3057613A1 (en) * 2017-03-15 2018-09-20 Juneau Biosciences, L.L.C. Methods of using genetic markers associated with endometriosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032920A2 (en) * 1999-11-03 2001-05-10 Metris Therapeutics Limited Agents implicated in endometriosis
US20060014166A1 (en) * 2004-01-27 2006-01-19 Yossi Cohen Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis
BRPI0520012A2 (pt) * 2005-02-18 2009-04-14 Us Gov Health & Human Serv identificação de marcadores moleculares de diagnóstico para endometriose em linfócitos do sangue
US20100081129A1 (en) * 2005-04-29 2010-04-01 Abdelmajid Belouchi Genemap of the human genes associated with crohn's disease
US20110038845A1 (en) * 2005-05-05 2011-02-17 Mohamed Bedaiwy Diagnosis and treatment for endometriosis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US9840738B2 (en) 2007-06-11 2017-12-12 Juneau Biosciences, Llc Method of testing for endometriosis and treatment therefor
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor

Also Published As

Publication number Publication date
WO2008123901A3 (en) 2009-02-19
WO2008123901A2 (en) 2008-10-16
EP2118321A2 (de) 2009-11-18
EP2118321A4 (de) 2010-06-30

Similar Documents

Publication Publication Date Title
US20100144538A1 (en) Genemap of the human genes associated with schizophrenia
US20100291551A1 (en) Genemap of the human associated with crohn's disease
US20100120628A1 (en) Genemap of the human genes associated with adhd
US20100120627A1 (en) Genemap of the human genes associated with psoriasis
US20090305900A1 (en) Genemap of the human genes associated with longevity
WO2008024114A1 (en) Genemap of the human genes associated with schizophrenia
US20090081658A1 (en) Genemap of the human genes associated with crohn's disease
US20090181380A1 (en) Genemap of the human genes associated with crohn's disease
US20100099083A1 (en) Crohn disease susceptibility gene
US20090098557A1 (en) Identification of genetic markers associated with parkinson disease
JP2010527603A (ja) 乳癌のリスクアセスメント、診断、予後診断および治療における使用のためのマーカーとしてのCHR5p12および10q26上の遺伝的変異
JP2010507388A (ja) Chr8q24.21上の癌感受性変異体
WO2009026116A2 (en) Genemap of the human genes associated with longevity
ES2367566T3 (es) Uso de polimorfismos genéticos que se asocian con la eficacia del tratamiento de una enfermedad inflamatoria.
EP2082343A2 (de) Genkarte der mit asthmaerkrankung assoziierten menschlichen gene
CA2676415A1 (en) Genemap of the human genes associated with endometriosis
WO2009039244A2 (en) Genemap of the human genes associated with crohn's disease
US20100167285A1 (en) Methods and agents for evaluating inflammatory bowel disease, and targets for treatment
WO2008055196A2 (en) Genemap of the human genes associated with male pattern baldness
JP2004508056A (ja) 5−ヒドロキシトリプタミン受容体遺伝子多型、および治療に対する応答
WO2010033825A2 (en) Genetic variants associated with abdominal aortic aneurysms
Jaakkola Investigating genetic determinants of ankylosing spondylitis
BELOUCHI et al. Patent 2620082 Summary

Legal Events

Date Code Title Description
FZDE Discontinued